Analytical Data
-
基因名
OVA
- Application
-
别名
OVA；Ccr11；Lccr；C-C chemokine receptor-like 2
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O00421
-
表达区间
1-344aa
-
氨基酸序列
MANYTLAPEDEYDVLIEGELESDEAEQCDKYDAQALSAQLVPSLCSAVFVIGVLDNLLVVLILVKYKGLKRVENIYLLNLAVSNLCFLLTLPFWAHAGGDPMCKILIGLYFVGLYSETFFNCLLTVQRYLVFLHKGNFFSARRRVPCGIITSVLAWVTAILATLPEFVVYKPQMEDQKYKCAFSRTPFLPADETFWKHFLTLKMNISVLVLPLFIFTFLYVQMRKTLRFREQRYSLFKLVFAIMVVFLLMWAPYNIAFFLSTFKEHFSLSDCKSSYNLDKSVHITKLIATTHCCINPLLYAFLDGTFSKYLCRCFHLRSNTPLQPRGQSAQGTSREEPDHSTEV
-
分子量
39.5 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of OVA (ovalbumin) recombinant proteins has garnered significant interest in the fields of immunology and biotechnology due to their potential applications in vaccine development and allergen research. Ovalbumin, a major allergen found in egg whites, serves as a model protein for studying immune responses, particularly in the context of allergic reactions and tolerance induction. The recombinant version of OVA can be produced using various expression systems, including bacteria, yeast, and mammalian cells, allowing researchers to generate specific mutations or modifications that can enhance its immunogenic properties or alter its allergenic potential. This versatility enables the design of tailored proteins for therapeutic use, such as in allergy immunotherapy, where OVA can be used to sensitively assess immune responses in preclinical models. Moreover, understanding the structure-function relationship of OVA through recombinant techniques aids in deciphering the underlying mechanisms of immune recognition and activation. As such, the research into OVA recombinant proteins not only advances our fundamental knowledge of immunological processes but also holds promise for innovative approaches to treating allergies and designing novel vaccines, contributing to improved public health outcomes.
